Who is sponsoring NCT04660903?

NCT04660903 is sponsored by Konstantinos Tsimogiannis.

What drugs are being tested in NCT04660903?

Interventions in NCT04660903: Autologous fat cell transplantation.

What condition does NCT04660903 study?

NCT04660903 studies Fistula in Ano, Transsphincteric Anal Fistula.

Is NCT04660903 still recruiting?

NCT04660903 is currently suspended. Last updated 13 June 2022.

Last reviewed 2022-06-13 · How we verify

NCT04660903

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Fistula in Ano With Autologous Fatty Tissue Cells Transplantation

Suspended NA Last updated 13 June 2022

What this trial tests

NA trial testing Autologous fat cell transplantation in Fistula in Ano in 30 participants. Suspended.

Timeline

1 October 2020

Primary endpoint
30 October 2023

28 February 2024

Quick facts

Lead sponsor	Konstantinos Tsimogiannis
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 October 2020
Primary completion	30 October 2023
Estimated completion	28 February 2024
Sites	1 location across Sweden

Drugs / interventions tested

Autologous fat cell transplantation

Conditions studied

Fistula in Ano — all drugs for Fistula in Ano →
Transsphincteric Anal Fistula — all drugs for Transsphincteric Anal Fistula →

Sponsor

Konstantinos Tsimogiannis

Who can join

Adults 18 to 75, any sex, with Fistula in Ano or Transsphincteric Anal Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective interventional study on the treatment of transsphincteric fistula in ano. After abdominal or thigh liposuction, fat was injected around the fistula tract that was then transected percutaneously with a sharp cannula and fat injected between and around the cut parts. The internal opening was closed with a suture. Minimum follow up of 12 months is planed

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fistula in Ano

Currently open trials in the same condition.

NCT07519850 — The Impact of Perianal Disease on Patient's Sex Life · recruiting
NCT07035925 — Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas · NA · recruiting
NCT05666609 — Fistula-in-ano in Infants and Children · NA · recruiting
NCT05039411 — Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease · Phase 1 · recruiting
NCT04187651 — PRP Use in Treatment of Fistula Ano · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04660903 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Konstantinos Tsimogiannis
Last refreshed: 13 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing